A medical worker inoculates an old woman with a dose of a COVID-19 vaccine in Neikeng town of Jinjiang city, southeast China's Fujian province, Aug 31, 2021. (SONG WEIWEI / XINHUA)
BEIJING/SHANGHAI – The Chinese mainland on Tuesday reported no new locally transmitted COVID-19 cases and 19 fresh imported infections, the National Health Commission said in its daily report on Wednesday.
Of the new cases, six were reported in Guangdong, four in Yunnan, three in Shanghai, two in Tianjin, and one each in Beijing, Zhejiang, Fujian and Guangxi.
The total number of confirmed COVID-19 cases on the mainland reached 94,898 by Tuesday, including 89,240 recoveries. The death toll was unchanged at 4,636
Two suspected cases arriving from outside the mainland were reported in Shanghai, the commission said, adding that there were no additional deaths related to COVID-19.
ALSO READ: Research on link of COVID-19, cold chain urged
There were 1,022 patients still receiving treatment, three of whom were in severe condition, it said.
By the end of Tuesday, a total of 8,340 imported cases had been reported with no deaths.
Overall, the total number of confirmed COVID-19 cases on the mainland reached 94,898 by Tuesday, including 89,240 recoveries. The death toll was unchanged at 4,636.
Meanwhile, 13 new asymptomatic cases, all arriving from outside the mainland, were also reported. There were a total of 436 asymptomatic cases, of whom 380 were imported, under medical observation.
READ MORE: China recommends boosters for select groups as doses hit 2b
By the end of Tuesday, 12,112 confirmed COVID-19 cases, including 212 deaths, had been reported in the Hong Kong Special Administrative Region (SAR), 63 cases in the Macao SAR, and 15,995 cases, including 835 deaths, in Taiwan.
A total of 11,791 COVID-19 patients in the Hong Kong SAR had been discharged from hospitals following recovery, 60 in the Macao SAR, and 13,676 in Taiwan.
More than 2.06 billion doses of COVID-19 vaccines had been administered across the mainland as of Tuesday, the commission said.
Shots provided by Fosun Pharma expected to arrive in Taipei
The first batch of COVID-19 mRNA vaccines provided by the Shanghai-based Fosun Pharma to Taiwan is expected to arrive in Taipei on Thursday morning.
A total of 932,000 doses of the vaccines have been dispatched from Luxembourg Airport on Wednesday afternoon (Beijing time), said the company, adding that the second batch of 910,000 doses will start delivery in a week.
The COVID-19 mRNA vaccine developed by Fosun Pharma and BioNTech received authorization for emergency use and special import in the Hong Kong and Macao SARs earlier this year. The vaccine is included under the vaccination programs of the two SARs' governments.